Stay updated with our curated selection of the latest allergy news and more! FDA Approves TEZSPIRE® For Chronic Rhinosinusitis With Nasal PolypsAmgen Read Here: https://wwwext.amgen.com/newsroom/press-releases/2025/10/fda-approves-tezspire-for-chronic-rhinosinusitis-with-nasal-polyps Advice to Feed Babies Peanuts Early and Often Helped Thousands of Kids Avoid AllergiesPBS News…
Targeted Molecular Therapies in Allergy and Rhinology
AAOA’s “Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin.
The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases.
Biologic drugs are monoclonal antibodies targeting specific Type ll inflammation molecular pathways for a variety of disease entities in the head and neck.
Read the article here:




